Physical activity and cancer risk: dose-response and cancer, all sites and site-specific

Author(s): Thune I, Furberg AS

Abstract

Purpose: The association between physical activity and overall and site-specific cancer risk is elaborated in relation to whether any observed dose-response association between physical activity and cancer can be interpreted in terms of how much physical activity (type, intensity, duration, frequency) is needed to influence site- and gender-specific cancer risk.

Methods: Observational studies were reviewed that have examined the independent effect of the volume of occupational physical activity (OPA) and/or leisure time physical activity (LPA) on overall and site-specific cancer risk.

Results: The evidence of cohort and case-control studies suggests that both leisure time and occupational physical activity protect against overall cancer risk, with a graded dose-response association suggested in both sexes. Confounding effects such as diet, body weight, and parity are often included as a covariate in the analyses, with little influence on the observed associations. A crude graded inverse dose-response association was observed between physical activity and colon cancer in 48 studies including 40,674 colon/colorectal cancer cases for both sexes. A dose-response effect of physical activity on colon cancer risk was especially observed, when participation in activities of at least moderate activity (>4.5 MET) and demonstrated by activities expressed as MET-hours per week. An observed inverse association with a dose-response relationship between physical activity and breast cancer was also identified in the majority of the 41 studies including 108,031 breast cancer cases. The dose-response relationship was in particular observed in case-control studies and supported by observations in cohort studies when participation in activities of at least moderate activity (>4.5 MET) and demonstrated by activities expressed by MET-hours per week. This association between physical activity and breast cancer risk is possibly dependent on age at exposure, age at diagnosis, menopausal status and other effect modifiers, e.g., body mass index. Furthermore, data concerning carcinoma of other cancers (prostate, lung, endometrium, ovary, and testicular cancers) are required.

Conclusion: A protective effect of physical activity on site-specific cancer risk with a dose-response association between physical activity and colon and pre- and postmenopausal breast cancer supported by identified biological mechanisms has been observed. The optimal permutation of type, intensity, duration, and frequency of physical activity across the lifespan is unclear, but it is gender, age, and site specific and supports moderate activity (>4.5 MET) more than light activities (<4.5 MET). The complicated nature of the physical activity variable, combined with lack of knowledge regarding possible biological mechanisms operating between physical activity and cancer, warrants further studies including controlled clinical randomized trials.

Similar Articles

Incidence of endometrial hyperplasia

Author(s): Reed SD, Newton KM, Clinton WL, Epplein M, Garcia R, et al.

Seromucinous Tumors of the Ovary

Author(s): Kurman RJ, Shih IeM

Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia

Author(s): Lacey JV Jr, Sherman ME, Rush BB, Ronnett BM, Ioffe OB, et al.

Modifiable risk factors for cancer

Author(s): Stein CJ, Colditz GA

Complex hyperplasia with and without atypia: clinical outcomes and implications of progestin therapy

Author(s): Reed SD, Newton KM, Garcia RL, Allison KH, Voigt LF, et al.

Risk factors for endometrial hyperplasia: results from a case-control study

Author(s): Ricci E, Moroni S, Parazzini F, Surace M, Benzi G, et al.

High rate of endometrial hyperplasia in renal transplanted women

Author(s): Bobrowska K, Kamiński P, Cyganek A, Pietrzak B, Jabiry-Zieniewicz Z, et al.

Clinical parameters linked with malignancy in endometrial polyps

Author(s): Gregoriou O, Konidaris S, Vrachnis N, Bakalianou K, Salakos N, et al.

Measuring inconsistency in meta-analyses

Author(s): Higgins JP, Thompson SG, Deeks JJ, Altman DG

Quantifying heterogeneity in a meta-analysis

Author(s): Higgins JP, Thompson SG

Bias in meta-analysis detected by a simple, graphical test

Author(s): Egger M, Davey Smith G, Schneider M, Minder C

Prevalence of endometrial cancer and hyperplasia in non-symptomatic overweight and obese women

Author(s): Viola AS, Gouveia D, Andrade L, Aldrighi JM, Viola CF, et al.

Risk factors for adenomatous endometrial hyperplasia: a case-control study

Author(s): Kreiger N, Marrett LD, Clarke EA, Hilditch S, Woolever CA

Endometrial hyperplasia risk in relation to recent use of oral contraceptives and hormone therapy

Author(s): Epplein M, Reed SD, Voigt LF, Newton KM, Holt VL, et al.

The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis

Author(s): Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, et al.

Characteristics of women with a family history of ovarian cancer

Author(s): Cramer DW, Barbieri RL, Muto MG, Kelly A, Brucks JP, et al.

Cigarette smoking, relative weight, and menopause

Author(s): Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, et al.

Tobacco smoking and cancer: a meta-analysis

Author(s): Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, et al.

Smoking and colorectal cancer: a meta-analysis

Author(s): Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, et al.

An aggregated analysis of hormonal factors and endometrial cancer risk by parity

Author(s): Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, et al.

IUD use and the risk of endometrial cancer

Author(s): Benshushan A, Paltiel O, Rojansky N, Brzezinski A, Laufer N

Risk factors among young women with endometrial cancer: a Danish case-control study

Author(s): Parslov M, Lidegaard O, Klintorp S, Pedersen B, Jønsson L, et al.

A case-control study of cancer of the endometrium

Author(s): Kelsey JL, LiVolsi VA, Holford TR, Fischer DB, Mostow ED, et al.

Epidemiology of endometrial cancer

Author(s): Elwood JM, Cole P, Rothman KJ, Kaplan SD

Family history and the risk of endometrial cancer

Author(s): Parazzini F, La Vecchia C, Moroni S, Chatenoud L, Ricci E